Overview
Financials
Revenue history
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 5 of 6 financial statements were filed late (the longest delay 784 days for 2018).
- 2024not filed
- 202321/06/2024
- 202221/06/2024
- 202123/06/2023
- 202011/05/2022
- 201906/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Manner of representation
The President of the Management Board is entitled to represent the company externally independently and to make, receive and sign declarations on behalf of the company. Each Vice-President of the Management Board is entitled to represent the company externally and to make and sign declarations on behalf of the company exclusively by way of joint representation with the President of the Management Board.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jarosław Zygmunt Konarzewskiage 65 | 40 | $540.25 | 40% |
Jarosław Romanowskiage 56 | 40 | $540.25 | 40% |
Karsten Friedbert Theobald | 10 | $135.06 | 10% |
Jörg Wenskowski | 10 | $135.06 | 10% |
Beneficial owners
No beneficial owners recorded for the company Kr-Biotech.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| DOZ Directsp. k. | $767,165,903.98 | doz.pl | ||
| Chde PolskaS.A. | $17,544,214.35 | chde.pl | ||
| Medicavera Dahlhausen Groupsp. z o.o. | $7,393,838.95 | medicavera.pl | ||
| Fortis Pharmaceuticalssp. z o.o. | $6,911,557.57 | fortispharmaceuticals.pl | ||
| TDFS.A. | $5,168,316.22 | tdfsa.pl | ||
| LM Linesp. z o.o. | $3,541,531.01 | lmline.pl | ||
| Novartagsp. z o.o. | $2,269,221.93 | novartag.pl | ||
| Medpipesp. z o.o. | $1,191,948.44 | medpipe.pl | ||
| BL Medicasp. z o.o. + limited partnership | $886,794.58 | blmedica.pl | ||
| BL Medicasp. z o.o. | $148,305.98 | blmedica.pl |
FAQ
Last updated: 2026-04-07